Login to Your Account



Other news to note


Tuesday, May 6, 2014
Kinex Pharmaceuticals Inc., of Buffalo, N.Y., said it has filed an investigational new drug application (IND) for Oratecan, an oral form of the chemotherapy agent irinotecan with enhanced oral absorption.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription